nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—Dactinomycin—testicular cancer	0.0937	0.163	CbGbCtD
Reboxetine—CYP3A4—Ifosfamide—testicular cancer	0.0663	0.115	CbGbCtD
Reboxetine—ABCB1—Vinblastine—testicular cancer	0.0587	0.102	CbGbCtD
Reboxetine—CYP2D6—Vinblastine—testicular cancer	0.0553	0.0963	CbGbCtD
Reboxetine—ABCB1—Cisplatin—testicular cancer	0.0538	0.0937	CbGbCtD
Reboxetine—ABCB1—Etoposide—testicular cancer	0.0529	0.0921	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—testicular cancer	0.0361	0.0628	CbGbCtD
Reboxetine—CYP3A4—Vinblastine—testicular cancer	0.0352	0.0613	CbGbCtD
Reboxetine—ABCB1—Methotrexate—testicular cancer	0.035	0.0609	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—testicular cancer	0.034	0.0592	CbGbCtD
Reboxetine—CYP3A4—Etoposide—testicular cancer	0.0317	0.0552	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—testicular cancer	0.0216	0.0376	CbGbCtD
Reboxetine—Hypersensitivity—Ifosfamide—testicular cancer	0.000523	0.00123	CcSEcCtD
Reboxetine—Muscular weakness—Doxorubicin—testicular cancer	0.000522	0.00123	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000522	0.00123	CcSEcCtD
Reboxetine—Dysuria—Epirubicin—testicular cancer	0.000517	0.00121	CcSEcCtD
Reboxetine—Conjunctivitis—Methotrexate—testicular cancer	0.000512	0.0012	CcSEcCtD
Reboxetine—Influenza—Doxorubicin—testicular cancer	0.000511	0.0012	CcSEcCtD
Reboxetine—Pollakiuria—Epirubicin—testicular cancer	0.000511	0.0012	CcSEcCtD
Reboxetine—Asthenia—Ifosfamide—testicular cancer	0.000509	0.0012	CcSEcCtD
Reboxetine—Sweating—Methotrexate—testicular cancer	0.000505	0.00119	CcSEcCtD
Reboxetine—Feeling abnormal—Cisplatin—testicular cancer	0.000504	0.00118	CcSEcCtD
Reboxetine—Paraesthesia—Etoposide—testicular cancer	0.000503	0.00118	CcSEcCtD
Reboxetine—Weight decreased—Epirubicin—testicular cancer	0.0005	0.00117	CcSEcCtD
Reboxetine—Dyspnoea—Etoposide—testicular cancer	0.0005	0.00117	CcSEcCtD
Reboxetine—Hyperglycaemia—Epirubicin—testicular cancer	0.000499	0.00117	CcSEcCtD
Reboxetine—Somnolence—Etoposide—testicular cancer	0.000498	0.00117	CcSEcCtD
Reboxetine—Epistaxis—Methotrexate—testicular cancer	0.000497	0.00117	CcSEcCtD
Reboxetine—Nausea—Bleomycin—testicular cancer	0.000493	0.00116	CcSEcCtD
Reboxetine—Infestation—Epirubicin—testicular cancer	0.000493	0.00116	CcSEcCtD
Reboxetine—Infestation NOS—Epirubicin—testicular cancer	0.000493	0.00116	CcSEcCtD
Reboxetine—Vomiting—Dactinomycin—testicular cancer	0.000493	0.00116	CcSEcCtD
Reboxetine—Bronchitis—Doxorubicin—testicular cancer	0.000492	0.00116	CcSEcCtD
Reboxetine—Rash—Dactinomycin—testicular cancer	0.000488	0.00115	CcSEcCtD
Reboxetine—Decreased appetite—Etoposide—testicular cancer	0.000487	0.00115	CcSEcCtD
Reboxetine—Diarrhoea—Ifosfamide—testicular cancer	0.000486	0.00114	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000484	0.00114	CcSEcCtD
Reboxetine—Body temperature increased—Cisplatin—testicular cancer	0.000484	0.00114	CcSEcCtD
Reboxetine—Constipation—Etoposide—testicular cancer	0.000479	0.00113	CcSEcCtD
Reboxetine—Urinary tract infection—Epirubicin—testicular cancer	0.000479	0.00113	CcSEcCtD
Reboxetine—Conjunctivitis—Epirubicin—testicular cancer	0.000479	0.00113	CcSEcCtD
Reboxetine—Dysuria—Doxorubicin—testicular cancer	0.000478	0.00112	CcSEcCtD
Reboxetine—Sweating—Epirubicin—testicular cancer	0.000472	0.00111	CcSEcCtD
Reboxetine—Pollakiuria—Doxorubicin—testicular cancer	0.000472	0.00111	CcSEcCtD
Reboxetine—Dizziness—Ifosfamide—testicular cancer	0.000469	0.0011	CcSEcCtD
Reboxetine—Pharyngitis—Methotrexate—testicular cancer	0.000469	0.0011	CcSEcCtD
Reboxetine—Urinary tract disorder—Methotrexate—testicular cancer	0.000467	0.0011	CcSEcCtD
Reboxetine—Epistaxis—Epirubicin—testicular cancer	0.000465	0.00109	CcSEcCtD
Reboxetine—Urethral disorder—Methotrexate—testicular cancer	0.000463	0.00109	CcSEcCtD
Reboxetine—Weight decreased—Doxorubicin—testicular cancer	0.000463	0.00109	CcSEcCtD
Reboxetine—Sinusitis—Epirubicin—testicular cancer	0.000462	0.00109	CcSEcCtD
Reboxetine—Feeling abnormal—Etoposide—testicular cancer	0.000462	0.00109	CcSEcCtD
Reboxetine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000461	0.00108	CcSEcCtD
Reboxetine—Nausea—Dactinomycin—testicular cancer	0.00046	0.00108	CcSEcCtD
Reboxetine—Gastrointestinal pain—Etoposide—testicular cancer	0.000459	0.00108	CcSEcCtD
Reboxetine—Infestation NOS—Doxorubicin—testicular cancer	0.000456	0.00107	CcSEcCtD
Reboxetine—Infestation—Doxorubicin—testicular cancer	0.000456	0.00107	CcSEcCtD
Reboxetine—Visual impairment—Methotrexate—testicular cancer	0.000456	0.00107	CcSEcCtD
Reboxetine—Vomiting—Ifosfamide—testicular cancer	0.000451	0.00106	CcSEcCtD
Reboxetine—Hypersensitivity—Cisplatin—testicular cancer	0.000451	0.00106	CcSEcCtD
Reboxetine—Bradycardia—Epirubicin—testicular cancer	0.00045	0.00106	CcSEcCtD
Reboxetine—Rash—Ifosfamide—testicular cancer	0.000448	0.00105	CcSEcCtD
Reboxetine—Dermatitis—Ifosfamide—testicular cancer	0.000447	0.00105	CcSEcCtD
Reboxetine—Urticaria—Etoposide—testicular cancer	0.000445	0.00105	CcSEcCtD
Reboxetine—Rhinitis—Epirubicin—testicular cancer	0.000444	0.00104	CcSEcCtD
Reboxetine—Body temperature increased—Etoposide—testicular cancer	0.000443	0.00104	CcSEcCtD
Reboxetine—Abdominal pain—Etoposide—testicular cancer	0.000443	0.00104	CcSEcCtD
Reboxetine—Conjunctivitis—Doxorubicin—testicular cancer	0.000443	0.00104	CcSEcCtD
Reboxetine—Urinary tract infection—Doxorubicin—testicular cancer	0.000443	0.00104	CcSEcCtD
Reboxetine—Eye disorder—Methotrexate—testicular cancer	0.000442	0.00104	CcSEcCtD
Reboxetine—Tinnitus—Methotrexate—testicular cancer	0.000441	0.00104	CcSEcCtD
Reboxetine—Asthenia—Cisplatin—testicular cancer	0.000439	0.00103	CcSEcCtD
Reboxetine—Pharyngitis—Epirubicin—testicular cancer	0.000439	0.00103	CcSEcCtD
Reboxetine—Cardiac disorder—Methotrexate—testicular cancer	0.000439	0.00103	CcSEcCtD
Reboxetine—Sweating—Doxorubicin—testicular cancer	0.000437	0.00103	CcSEcCtD
Reboxetine—Urinary tract disorder—Epirubicin—testicular cancer	0.000437	0.00103	CcSEcCtD
Reboxetine—Connective tissue disorder—Epirubicin—testicular cancer	0.000435	0.00102	CcSEcCtD
Reboxetine—Urethral disorder—Epirubicin—testicular cancer	0.000434	0.00102	CcSEcCtD
Reboxetine—Epistaxis—Doxorubicin—testicular cancer	0.00043	0.00101	CcSEcCtD
Reboxetine—Angiopathy—Methotrexate—testicular cancer	0.000429	0.00101	CcSEcCtD
Reboxetine—Sinusitis—Doxorubicin—testicular cancer	0.000428	0.00101	CcSEcCtD
Reboxetine—Immune system disorder—Methotrexate—testicular cancer	0.000427	0.001	CcSEcCtD
Reboxetine—Visual impairment—Epirubicin—testicular cancer	0.000426	0.001	CcSEcCtD
Reboxetine—Mediastinal disorder—Methotrexate—testicular cancer	0.000426	0.001	CcSEcCtD
Reboxetine—Chills—Methotrexate—testicular cancer	0.000424	0.000997	CcSEcCtD
Reboxetine—Nausea—Ifosfamide—testicular cancer	0.000422	0.000991	CcSEcCtD
Reboxetine—Diarrhoea—Cisplatin—testicular cancer	0.000419	0.000984	CcSEcCtD
Reboxetine—Bradycardia—Doxorubicin—testicular cancer	0.000417	0.000979	CcSEcCtD
Reboxetine—Mental disorder—Methotrexate—testicular cancer	0.000414	0.000973	CcSEcCtD
Reboxetine—Eye disorder—Epirubicin—testicular cancer	0.000413	0.000971	CcSEcCtD
Reboxetine—Hypersensitivity—Etoposide—testicular cancer	0.000413	0.000971	CcSEcCtD
Reboxetine—Tinnitus—Epirubicin—testicular cancer	0.000412	0.000969	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—testicular cancer	0.000412	0.000967	CcSEcCtD
Reboxetine—Cardiac disorder—Epirubicin—testicular cancer	0.000411	0.000965	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—testicular cancer	0.00041	0.000964	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—testicular cancer	0.000406	0.000954	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000404	0.00095	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—testicular cancer	0.000403	0.000947	CcSEcCtD
Reboxetine—Asthenia—Etoposide—testicular cancer	0.000402	0.000945	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000402	0.000945	CcSEcCtD
Reboxetine—Angiopathy—Epirubicin—testicular cancer	0.000401	0.000943	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—testicular cancer	0.000401	0.000943	CcSEcCtD
Reboxetine—Immune system disorder—Epirubicin—testicular cancer	0.0004	0.000939	CcSEcCtD
Reboxetine—Mediastinal disorder—Epirubicin—testicular cancer	0.000399	0.000937	CcSEcCtD
Reboxetine—Chills—Epirubicin—testicular cancer	0.000397	0.000933	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—testicular cancer	0.000394	0.000927	CcSEcCtD
Reboxetine—Vomiting—Cisplatin—testicular cancer	0.000389	0.000914	CcSEcCtD
Reboxetine—Mental disorder—Epirubicin—testicular cancer	0.000388	0.000911	CcSEcCtD
Reboxetine—Rash—Cisplatin—testicular cancer	0.000386	0.000907	CcSEcCtD
Reboxetine—Dermatitis—Cisplatin—testicular cancer	0.000386	0.000906	CcSEcCtD
Reboxetine—Malnutrition—Epirubicin—testicular cancer	0.000385	0.000905	CcSEcCtD
Reboxetine—Diarrhoea—Etoposide—testicular cancer	0.000384	0.000901	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—testicular cancer	0.000383	0.000899	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—testicular cancer	0.000382	0.000897	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—testicular cancer	0.000382	0.000897	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—testicular cancer	0.00038	0.000894	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—testicular cancer	0.00038	0.000893	CcSEcCtD
Reboxetine—Tension—Epirubicin—testicular cancer	0.000378	0.000888	CcSEcCtD
Reboxetine—Dysgeusia—Epirubicin—testicular cancer	0.000377	0.000886	CcSEcCtD
Reboxetine—Nervousness—Epirubicin—testicular cancer	0.000374	0.000879	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—testicular cancer	0.000371	0.000873	CcSEcCtD
Reboxetine—Malaise—Methotrexate—testicular cancer	0.000371	0.000872	CcSEcCtD
Reboxetine—Dizziness—Etoposide—testicular cancer	0.000371	0.000871	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—testicular cancer	0.00037	0.000869	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—testicular cancer	0.00037	0.000869	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000369	0.000867	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—testicular cancer	0.000368	0.000865	CcSEcCtD
Reboxetine—Chills—Doxorubicin—testicular cancer	0.000367	0.000863	CcSEcCtD
Reboxetine—Nausea—Cisplatin—testicular cancer	0.000364	0.000854	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—testicular cancer	0.000359	0.000843	CcSEcCtD
Reboxetine—Ill-defined disorder—Epirubicin—testicular cancer	0.000357	0.000839	CcSEcCtD
Reboxetine—Vomiting—Etoposide—testicular cancer	0.000357	0.000838	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—testicular cancer	0.000356	0.000837	CcSEcCtD
Reboxetine—Anaemia—Epirubicin—testicular cancer	0.000356	0.000836	CcSEcCtD
Reboxetine—Agitation—Epirubicin—testicular cancer	0.000354	0.000831	CcSEcCtD
Reboxetine—Rash—Etoposide—testicular cancer	0.000354	0.000831	CcSEcCtD
Reboxetine—Dermatitis—Etoposide—testicular cancer	0.000353	0.00083	CcSEcCtD
Reboxetine—Headache—Etoposide—testicular cancer	0.000351	0.000825	CcSEcCtD
Reboxetine—Chest pain—Methotrexate—testicular cancer	0.00035	0.000823	CcSEcCtD
Reboxetine—Tension—Doxorubicin—testicular cancer	0.00035	0.000821	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—testicular cancer	0.000349	0.00082	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000348	0.000817	CcSEcCtD
Reboxetine—Malaise—Epirubicin—testicular cancer	0.000347	0.000816	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—testicular cancer	0.000346	0.000813	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—testicular cancer	0.000346	0.000813	CcSEcCtD
Reboxetine—Vertigo—Epirubicin—testicular cancer	0.000346	0.000813	CcSEcCtD
Reboxetine—Syncope—Epirubicin—testicular cancer	0.000345	0.000811	CcSEcCtD
Reboxetine—Leukopenia—Epirubicin—testicular cancer	0.000345	0.00081	CcSEcCtD
Reboxetine—Palpitations—Epirubicin—testicular cancer	0.00034	0.0008	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—testicular cancer	0.000339	0.000796	CcSEcCtD
Reboxetine—Loss of consciousness—Epirubicin—testicular cancer	0.000338	0.000795	CcSEcCtD
Reboxetine—Infection—Methotrexate—testicular cancer	0.000334	0.000784	CcSEcCtD
Reboxetine—Nausea—Etoposide—testicular cancer	0.000333	0.000782	CcSEcCtD
Reboxetine—Hypertension—Epirubicin—testicular cancer	0.000332	0.000781	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000331	0.000777	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—testicular cancer	0.000329	0.000774	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—testicular cancer	0.000329	0.000774	CcSEcCtD
Reboxetine—Chest pain—Epirubicin—testicular cancer	0.000328	0.00077	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—testicular cancer	0.000327	0.000769	CcSEcCtD
Reboxetine—Anxiety—Epirubicin—testicular cancer	0.000327	0.000768	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—testicular cancer	0.000326	0.000766	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000326	0.000765	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—testicular cancer	0.000325	0.000763	CcSEcCtD
Reboxetine—Discomfort—Epirubicin—testicular cancer	0.000324	0.000761	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—testicular cancer	0.000321	0.000755	CcSEcCtD
Reboxetine—Dry mouth—Epirubicin—testicular cancer	0.000321	0.000753	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—testicular cancer	0.00032	0.000752	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—testicular cancer	0.00032	0.000752	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—testicular cancer	0.00032	0.000751	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—testicular cancer	0.000319	0.000749	CcSEcCtD
Reboxetine—Confusional state—Epirubicin—testicular cancer	0.000317	0.000745	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—testicular cancer	0.000315	0.00074	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—testicular cancer	0.000314	0.000737	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—testicular cancer	0.000313	0.000736	CcSEcCtD
Reboxetine—Infection—Epirubicin—testicular cancer	0.000312	0.000734	CcSEcCtD
Reboxetine—Shock—Epirubicin—testicular cancer	0.000309	0.000726	CcSEcCtD
Reboxetine—Nervous system disorder—Epirubicin—testicular cancer	0.000308	0.000724	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—testicular cancer	0.000308	0.000723	CcSEcCtD
Reboxetine—Tachycardia—Epirubicin—testicular cancer	0.000307	0.000721	CcSEcCtD
Reboxetine—Skin disorder—Epirubicin—testicular cancer	0.000305	0.000717	CcSEcCtD
Reboxetine—Hyperhidrosis—Epirubicin—testicular cancer	0.000304	0.000714	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—testicular cancer	0.000304	0.000714	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—testicular cancer	0.000303	0.000713	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—testicular cancer	0.000302	0.00071	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—testicular cancer	0.000302	0.000709	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000301	0.000708	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—testicular cancer	0.0003	0.000704	CcSEcCtD
Reboxetine—Anorexia—Epirubicin—testicular cancer	0.0003	0.000704	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—testicular cancer	0.000299	0.000703	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—testicular cancer	0.000299	0.000701	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—testicular cancer	0.000297	0.000697	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—testicular cancer	0.000296	0.000695	CcSEcCtD
Reboxetine—Hypotension—Epirubicin—testicular cancer	0.000294	0.00069	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—testicular cancer	0.000293	0.000689	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—testicular cancer	0.000292	0.000686	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00029	0.000681	CcSEcCtD
Reboxetine—Infection—Doxorubicin—testicular cancer	0.000289	0.000679	CcSEcCtD
Reboxetine—Shock—Doxorubicin—testicular cancer	0.000286	0.000672	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—testicular cancer	0.000285	0.00067	CcSEcCtD
Reboxetine—Insomnia—Epirubicin—testicular cancer	0.000284	0.000668	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—testicular cancer	0.000284	0.000667	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—testicular cancer	0.000282	0.000664	CcSEcCtD
Reboxetine—Paraesthesia—Epirubicin—testicular cancer	0.000282	0.000663	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000281	0.00066	CcSEcCtD
Reboxetine—Dyspnoea—Epirubicin—testicular cancer	0.00028	0.000658	CcSEcCtD
Reboxetine—Somnolence—Epirubicin—testicular cancer	0.000279	0.000656	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—testicular cancer	0.000277	0.000651	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—testicular cancer	0.000277	0.00065	CcSEcCtD
Reboxetine—Dyspepsia—Epirubicin—testicular cancer	0.000277	0.00065	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000275	0.000645	CcSEcCtD
Reboxetine—Decreased appetite—Epirubicin—testicular cancer	0.000273	0.000642	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—testicular cancer	0.000272	0.000638	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000271	0.000637	CcSEcCtD
Reboxetine—Constipation—Epirubicin—testicular cancer	0.000269	0.000631	CcSEcCtD
Reboxetine—Urticaria—Methotrexate—testicular cancer	0.000267	0.000627	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—testicular cancer	0.000266	0.000624	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—testicular cancer	0.000266	0.000624	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—testicular cancer	0.000263	0.000618	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—testicular cancer	0.000261	0.000614	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—testicular cancer	0.000259	0.000609	CcSEcCtD
Reboxetine—Feeling abnormal—Epirubicin—testicular cancer	0.000259	0.000608	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—testicular cancer	0.000259	0.000607	CcSEcCtD
Reboxetine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000257	0.000604	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—testicular cancer	0.000256	0.000601	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—testicular cancer	0.000253	0.000594	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000251	0.00059	CcSEcCtD
Reboxetine—Urticaria—Epirubicin—testicular cancer	0.00025	0.000587	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—testicular cancer	0.000249	0.000584	CcSEcCtD
Reboxetine—Abdominal pain—Epirubicin—testicular cancer	0.000248	0.000584	CcSEcCtD
Reboxetine—Body temperature increased—Epirubicin—testicular cancer	0.000248	0.000584	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—testicular cancer	0.000247	0.000581	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—testicular cancer	0.000241	0.000566	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—testicular cancer	0.00024	0.000563	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000238	0.000559	CcSEcCtD
Reboxetine—Hypersensitivity—Epirubicin—testicular cancer	0.000232	0.000544	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—testicular cancer	0.000231	0.000543	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—testicular cancer	0.00023	0.00054	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—testicular cancer	0.00023	0.00054	CcSEcCtD
Reboxetine—Diarrhoea—Methotrexate—testicular cancer	0.00023	0.00054	CcSEcCtD
Reboxetine—Asthenia—Epirubicin—testicular cancer	0.000226	0.00053	CcSEcCtD
Reboxetine—Dizziness—Methotrexate—testicular cancer	0.000222	0.000522	CcSEcCtD
Reboxetine—Diarrhoea—Epirubicin—testicular cancer	0.000215	0.000505	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—testicular cancer	0.000214	0.000503	CcSEcCtD
Reboxetine—Vomiting—Methotrexate—testicular cancer	0.000214	0.000502	CcSEcCtD
Reboxetine—Rash—Methotrexate—testicular cancer	0.000212	0.000497	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—testicular cancer	0.000212	0.000497	CcSEcCtD
Reboxetine—Headache—Methotrexate—testicular cancer	0.00021	0.000494	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—testicular cancer	0.000209	0.00049	CcSEcCtD
Reboxetine—Dizziness—Epirubicin—testicular cancer	0.000208	0.000488	CcSEcCtD
Reboxetine—Vomiting—Epirubicin—testicular cancer	0.0002	0.000469	CcSEcCtD
Reboxetine—Nausea—Methotrexate—testicular cancer	0.000199	0.000469	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—testicular cancer	0.000199	0.000467	CcSEcCtD
Reboxetine—Rash—Epirubicin—testicular cancer	0.000198	0.000466	CcSEcCtD
Reboxetine—Dermatitis—Epirubicin—testicular cancer	0.000198	0.000465	CcSEcCtD
Reboxetine—Headache—Epirubicin—testicular cancer	0.000197	0.000463	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—testicular cancer	0.000192	0.000452	CcSEcCtD
Reboxetine—Nausea—Epirubicin—testicular cancer	0.000187	0.000439	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—testicular cancer	0.000185	0.000434	CcSEcCtD
Reboxetine—Rash—Doxorubicin—testicular cancer	0.000183	0.000431	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—testicular cancer	0.000183	0.00043	CcSEcCtD
Reboxetine—Headache—Doxorubicin—testicular cancer	0.000182	0.000428	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—testicular cancer	0.000173	0.000406	CcSEcCtD
